Information about Foracort 200 Synchrobreathe Inhaler

The Foracort 200 Synchrobreathe Inhaler is a combination inhaler used for the management of asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients:

1. Formoterol: A long-acting beta2-agonist (LABA) that helps in relaxing the muscles in the airways, making it easier to breathe.
2. Budesonide: An inhaled corticosteroid (ICS) that reduces inflammation in the airways, helping to prevent asthma and COPD symptoms.

Key Information:

1. Indications: The Foracort 200 Synchrobreathe Inhaler is indicated for:

   • Asthma: Used as a maintenance treatment to control and prevent asthma symptoms such as wheezing and shortness of breath.
   • COPD: Helps manage symptoms in chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, by reducing inflammation and bronchospasm.

2. Dosage and Administration:

   • The usual dose is determined by a healthcare provider based on the severity of the condition and the patient's response to treatment.
   • It is typically used as a regular maintenance therapy, not as a rescue inhaler for acute symptoms.
   • The "200" in the name refers to the dosage of budesonide (200 micrograms) per inhalation, while formoterol dosage is typically around 6 micrograms per inhalation.
   • The Synchrobreathe inhaler is designed to deliver medication when the patient inhales, ensuring proper dosage and minimizing the need for coordination between pressing the inhaler and inhaling.

3. Side Effects:

   • Common: Throat irritation, hoarseness, cough, headache, and oral thrush (a fungal infection in the mouth).
   • Serious: Increased risk of pneumonia in COPD patients, potential for systemic corticosteroid effects such as adrenal suppression, and a slight risk of cardiovascular effects due to formoterol.

4. Precautions:

   • Regular Monitoring: It's important to regularly monitor lung function and check for potential side effects, especially in long-term use.
   • Rinse Mouth: Patients should rinse their mouth after each use to reduce the risk of oral thrush.
   • Not for Acute Symptoms: This inhaler is not intended for the relief of acute asthma or COPD symptoms. A separate rescue inhaler (like a short-acting beta-agonist) should be used for sudden symptoms.
   • Interactions: Can interact with other medications, such as beta-blockers and certain antifungals. Patients should inform their healthcare provider of all medications they are taking.

Usage Tips:

• Technique: Proper inhalation technique is crucial for the effectiveness of the medication. Patients should receive instruction on how to use the Synchrobreathe inhaler correctly.
• Adherence: Regular use as prescribed is important for managing chronic respiratory conditions and preventing flare-ups.